Ignite Creation Date:
2025-12-24 @ 10:44 PM
Ignite Modification Date:
2025-12-25 @ 8:15 PM
Study NCT ID:
NCT00345735
Status:
COMPLETED
Last Update Posted:
2012-05-07
First Post:
2006-06-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Intranasal Fentanyl for the Treatment of Breakthrough Pain in Cancer Patients (FT-017-IM)
Sponsor:
Nycomed
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
FT-017-IM
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Nycomed
Old Organization:
Clinical Trial Operations